Full history for every metric is available with a Kvantra account
Cannasouth Limited (CBD.NZ)
Key financial summary
Financials in NZD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | NZD m | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Operating profit | NZD m | -9 | -9 | |||||
| Net profit | NZD m | -0 | -2 | -4 | -2 | -8 | -9 | -9 |
| EPS reported | NZD | -0.04 | -0.04 | |||||
| Operating cashflow per share | NZD | -0.04 | -0.04 | |||||
| Capex per share | NZD | 0.00 | 0.00 | |||||
| FCF per share | NZD | -0.04 | -0.04 | |||||
| Free cash flow | NZD m | -9 | -3 | |||||
| Net debt | NZD m | 1 | 1 | |||||
| Book value equity | NZD m | 48 | 48 | |||||
| Book value per share | NZD | 0.19 | 0.19 | |||||
| Number of shares | m | 250.05 | 250.05 | |||||
| DPS (TTM paid) | NZD | 0.00 | 0.00 |
Financial summary
Financials in NZD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.69 | 0.67 | |||||
| P/S LTM | x | 34.80 | 33.89 | |||||
| P/FCF LTM | x | -3.59 | -10.30 | |||||
| EV/EBITDA LTM | x | -4.17 | -3.86 | |||||
| EV/Sales LTM | x | 37.52 | 34.71 | |||||
| Earnings Yield LTM | % | -26.50% | -35.97% | |||||
| FCF Yield | % | -27.87% | -9.71% | |||||
| Quality | ||||||||
| ROE | % | -18.23% | -29.28% | |||||
| ROIC | % | -16.22% | -16.22% | |||||
| Operating margin | % | -910.42% | -910.42% | |||||
| Gross margin | % | -127.65% | -127.65% | |||||
| FCF/Sales | % | -969.90% | -969.90% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +579.62% | +579.62% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.91 | -0.65 | |||||
| Net Debt/EBITDA | x | -0.30 | -0.30 | |||||
| EBIT/Net interest | x | -40.46 | -40.46 | |||||
| Net debt/market cap | % | 2.35% | 2.41% | |||||
| Net debt/Equity | x | 0.02 | 0.02 | |||||
| Gross debt/equity | x | 0.10 | 0.10 | |||||
Company overview
Cannasouth Limited operates as a biopharmaceutical firm within New Zealand, actively engaged in the entire lifecycle of cannabinoid-based pharmaceuticals and raw cannabis materials, from their initial research and development through to manufacturing and distribution. This company was founded in 2018 and maintains its headquarters in Hamilton, New Zealand.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Cannasouth Limited (CBD.NZ)
Cannasouth Limited operates as a biopharmaceutical firm within New Zealand, actively engaged in the entire lifecycle of cannabinoid-based pharmaceuticals and raw cannabis materials, from their initial research and development through to manufacturing and distribution. This company was founded in 2018 and maintains its headquarters in Hamilton, New Zealand.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free